SEC Form 4 · accession 0001000229-18-000027
CORE LABORATORIES N V · CLB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark F Elvig
Officer — VP, Counsel & Secretary
Period of report
Feb 13, 2018
Accepted (ET)
Feb 15, 2018 · 5:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001000229
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance SharesF1 | $0.00 | Feb 13, 2018 | A | 2,600 | A | — | — | Common Shares | 2,600 | 2,600 | D |
Explanation of responses
- F1This award vests at the end of a three-year performance period that begins on January 1, 2018 and ends on the last NYSE trading day of December 2020 (the "Performance Period"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. At the end of the Performance Period, 100% of the award will vest if the Company is in the top 75th percentile of Return On Invested Capital of the Bloomberg Peer Group as shown by data published by Bloomberg upon the close of the NYSE market on the last trading day of the Performance Period. If this criteria is not met, then no shares shall vest and the award shall be forfeited.